Abnormal alveolar development associated with elevated adenine nucleosides (Q44509570)

3 December 2017

Abnormal alveolar development associated with elevated adenine nucleosides (English)

1 reference

3 December 2017

David J Erle

4

0 references

Michael R. Blackburn

object named as

Michael R Blackburn

5

0 references

author name string

Suman K Banerjee

1

1 reference

PubMed ID

12855405

3 December 2017

Hays W J Young

2

1 reference

PubMed ID

12855405

3 December 2017

Andrea Barczak

3

1 reference

3 December 2017

10 July 2003

1 reference

American Journal of Respiratory Cell and Molecular Biology

3 December 2017

1 reference

3 December 2017

30

1 reference

3 December 2017

1

1 reference

3 December 2017

38-50

1 reference

Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection

3 December 2017

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Activation of the A3 adenosine receptor affects cell cycle progression and cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Exploring the metabolic and genetic control of gene expression on a genomic scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Cluster analysis and display of genome-wide expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Real time quantitative PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Adenosine-dependent airway inflammation and hyperresponsiveness in partially adenosine deaminase-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Programmed cell death contributes to postnatal lung development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Adenosine receptors: G protein-mediated signalling and the role of accessory proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Molecular regulation of lung development

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Impaired distal airway development in mice lacking elastin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Pulmonary hypoplasia in the myogenin null mouse embryo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Tissue transglutaminase is a caspase substrate during apoptosis. Cleavage causes loss of transamidating function and is a biochemical marker of caspase 3 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Hepatocyte growth factor induces transglutaminase activity that negatively regulates the growth signal in primary cultured hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

The molecular basis of lung morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Restricted expression pattern of vegf-d in the adult and fetal mouse: high expression in the embryonic lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Angiopoietin-1 and VEGF in vascular development and angiogenesis in hypoplastic lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Extracellular adenosine induces apoptosis of human arterial smooth muscle cells via A(2b)-purinoceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Adenosine as an endogenous mediator of hypoxia for induction of vascular endothelial growth factor mRNA in U-937 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Mesenchymal-epithelial interactions in lung development and repair: are modeling and remodeling the same process?

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Adenosine receptor ligands: potential as therapeutic agents in asthma and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

PDGF-A Signaling Is a Critical Event in Lung Alveolar Myofibroblast Development and Alveogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. Differential impact on pulmonary and immunologic abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Suppression of cell proliferation and programmed cell death by dexamethasone during postnatal lung development

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Ontogeny of apoptosis during lung development

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Stimulation of expression for the adenosine A2A receptor gene by hypoxia in PC12 cells. A potential role in cell protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

Adenosine in bronchoalveolar lavage fluid in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0102OC

21 January 2018

Identifiers

DOI

10.1165/RCMB.2003-0102OC

1 reference

3 December 2017

1 reference

PubMed ID

12855405